我們已在上線! 進一步了解
BBC圖示

Virtus Biotech Clinical Trials ETF

名稱 持股 交易金額 股數
變動
持股
變動
Goldman Sachs
1
Goldman Sachs
New York
US$362萬 -US$344萬 -100,000 -50%
Jane Street
2
Jane Street
New York
US$207萬 +US$137萬 +39,905 +232%
Virtu KCG Holdings
3
Virtu KCG Holdings
New York
US$113萬 +US$108萬 +31,275 新
LPL Financial
4
LPL Financial
California
US$89.7萬 +US$19.2萬 +5,571 +29%
Credit Suisse
5
Credit Suisse
Switzerland
US$51.1萬 -US$5,329 -155 -1%
Baker Avenue Asset Management
6
Baker Avenue Asset Management
California
US$25.4萬 -US$3.82萬 -1,110 -14%
Ladenburg Thalmann Financial Services
7
Ladenburg Thalmann Financial Services
Florida
US$8萬 +US$7.56萬 +2,200 新
UBS Group
8
UBS Group
Switzerland
US$3.1萬 +US$2.15萬 +624 +267%
American International Group
9
American International Group
New York
US$9,055 +US$8,595 +250 新
Morgan Stanley
10
Morgan Stanley
New York
US$3,000 -US$3,438 -100 -59%
Tower Research Capital (TRC)
11
Tower Research Capital (TRC)
New York
– -US$5.38萬 -1,566 -100%
MassMutual Private Wealth & Trust
12
MassMutual Private Wealth & Trust
Connecticut
– -US$8,143 -248 已平倉
Creative Planning
13
Creative Planning
Kansas
– -US$7,000 -200 已平倉